2024-10-21 16:30:00
From: Health Canada
Current status: Open
The consultation runs from October 21, 2024 to December 20, 2024.
As part of the Pediatric Drug Action Plan, Health Canada is working with stakeholders to develop a national list of priority pediatric drugs. This list identifies medications needed to address unmet pediatric health needs in Canada and to facilitate access to these medications in the country.
To find out more:
To participate
Share your ideas online
View the draft list and use the online form to provide us with your feedback. We will take into consideration all responses received as part of this consultation.
Reason for consultation
We hosted a 60-day online drug proposal process with members of the pediatric medical community and pharmacists. This process aimed to determine which drugs could be placed on the list of priority pediatric drugs. We appointed an external panel of pediatric experts who took these comments into account to develop an initial list for further review.
We are currently consulting with individuals in Canada on the proposed list. The consultation will last 60 days.
External reference group in pediatrics
People targeted by this consultation
This consultation is open to all people living in Canada, including patients, their family members, advocacy organizations and any other interested individuals.
Related information
To communicate with us
Center for Policy, Pediatrics and International Collaboration
Directorate of Biological Medicines and Radiopharmaceuticals
Health Products and Food Branch
Health Canada
Email: [email protected]
1729622769
#Give #opinion #Consultation #draft #national #list #priority #pediatric #drugs
